Related Experiment Video
Updated: Jun 8, 2026

09:07
Analyzing the Functions of Mast Cells In Vivo Using 'Mast Cell Knock-in' Mice
Published on: May 27, 2015
Recent advances in mast cell clonality and anaphylaxis
1Brigham & Women's Hospital, Division of Rheumatology, Immunology & Allergy 1 Jimmy Fund Way, Smith Building, Room 626B, Boston, MA 02445 USA.
F1000 Medicine Reports
|October 16, 2010
Summary
Clonal mast cells with the D816V c-kit mutation are found in anaphylaxis patients. This suggests a link between mast cell disorders and severe allergic reactions, even without typical systemic mastocytosis signs.
Area of Science:
- Hematology
- Immunology
- Genetics
Background:
- Mastocytosis is a condition caused by the clonal expansion of mast cells.
- The D816V c-kit mutation is a common driver of mast cell proliferation in mastocytosis.
- Recent research indicates clonal mast cells may be present in conditions beyond overt systemic mastocytosis.
Purpose of the Study:
- To investigate the presence of clonal mast cells with the D816V c-kit mutation in patients experiencing anaphylaxis.
- To determine if these clonal mast cells are associated with anaphylaxis in the absence of classic systemic mastocytosis diagnostic criteria.
Main Methods:
- Analysis of patient samples for the presence of mast cells.
- Genetic testing to identify the D816V c-kit mutation in mast cells.
- Clinical data review to assess anaphylaxis and systemic mastocytosis diagnostic findings.
Main Results:
- Clonal mast cells harboring the D816V c-kit mutation were identified in patients presenting with anaphylaxis.
- These findings were observed in individuals who did not meet the standard diagnostic criteria for systemic mastocytosis.
Conclusions:
- The D816V c-kit mutation in clonal mast cells may play a role in anaphylaxis, independent of systemic mastocytosis.
- This highlights a potential diagnostic and therapeutic target for unexplained anaphylaxis.
Related Concept Videos
Allergic Reactions: Anaphylaxis
Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin, heparin),...
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Allergic Reactions
Overview
Cross-reactivity
Overview
Drug Toxicity: Allergic Reactions
Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial exposure to a...
Allergic Drug Reactions
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing numerous...

